Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Depreciation & Amortization (CF) (2020 - 2025)

Agilon Health (AGL) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 7.31% year-over-year to $7.0 million, compared with a TTM value of $28.6 million through Dec 2025, up 16.89%, and an annual FY2025 reading of $28.6 million, up 16.89% over the prior year.
  • Depreciation & Amortization (CF) was $7.0 million for Q4 2025 at Agilon Health, down from $7.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $7.4 million in Q3 2025 and bottomed at $3.0 million in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $5.1 million, with a median of $5.2 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) fell 15.83% in 2022, then soared 81.3% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $3.6 million in 2021, then rose by 7.39% to $3.9 million in 2022, then skyrocketed by 31.74% to $5.1 million in 2023, then increased by 26.17% to $6.5 million in 2024, then rose by 7.31% to $7.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for AGL at $7.0 million in Q4 2025, $7.4 million in Q3 2025, and $7.3 million in Q2 2025.